Medexus Pharmaceuticals Inc.
Medexus Pharmaceuticals Inc. scores highest on Nitro (88) and lowest on Price (24). Its PosiPenta is 49.04 out of 100, around the middle of similar companies.
On the Penta Grid this week, Medexus Pharmaceuticals Inc. is Grid #5 of 8 in the Healthcare sector in Canada, and Grid #86 of 130 in Canada.
Compared with similar companies in the Healthcare sector in Canada.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Medexus Pharmaceuticals Inc. | 49.04 | 24 | 50 | 88 | 44 | 40 |
| Organigram Global Inc. | 57.94 | 91 | 54 | 29 | 66 | 49 |
| Cipher Pharmaceuticals Inc. | 64.27 | 71 | 59 | 44 | 76 | 72 |
| COSCIENS Biopharma Inc. | 27.32 | 46 | 0 | 16 | 36 | 38 |
| Quest PharmaTech Inc. | 59.22 | 98 | 84 | 17 | 69 | 27 |
| Zero Candida Technologies, Inc. | 30.60 | 0 | 36 | 15 | 56 | 46 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -55.22 |
| P/B ratio | 2.32 |
EEarnings
| Trailing EPS | ₹-6.12 |
| Forward EPS | ₹-1.36 |
NNitro
| Price | 337.76 |
| 52-week high | 373.77 |
| 52-week low | 170.58 |
| Fall from 52-week high | 9.6% |
TTorque
| Return on equity (ROE) | -4.68% |
| Debt-to-equity | 0.55 |
AAnchor
| Beta (price swings) | 1.73 |
| Market cap | ₹1,061 Cr |
| Insider holding | 8.02% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Medexus Pharmaceuticals Inc.'s PosiPenta score?
Medexus Pharmaceuticals Inc.'s PosiPenta is 49.04 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does Medexus Pharmaceuticals Inc. stand on the Penta Grid?
On the Penta Grid this week, Medexus Pharmaceuticals Inc. is Grid #5 of 8 in the Healthcare sector in Canada, and Grid #86 of 130 in Canada.
Which PosiPenta pillar is strongest for Medexus Pharmaceuticals Inc.?
Nitro (momentum), with a score of 88 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Medexus Pharmaceuticals Inc.?
Price (valuation), with a score of 24 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.